(−)-3β-Substituted Ecgonine Methyl Esters as Inhibitors for Cocaine Binding and Dopamine Uptake

Journal of Medicinal Chemistry
1998.0

Abstract

Ten 3 beta-ecgonine analogues were synthesized and characterized by 1H and 13C NMR, MS, and elemental analysis. The compounds were synthesized as (-)-stereoisomers from (-)-cocaine. These compounds were assessed for their ability to inhibit [3H]cocaine binding to rat striatal tissue and to inhibit [3H]DA uptake into rat striatal synaptosomes. In this series of compounds, the length of the spacer between the aryl group and the tropane skeleton ranged from 1 to 4 bond distances, and conformational flexibility of the linkage and orientation of the aryl ring system were controlled by various types of linkages. The most potent of the analogues was methyl-(1R-2-exo-3-exo)-8-methyl-3-(beta-styrenyl)-8-azabicyclo[3. 2.1] octane-2-carboxylate. One of the less potent compounds was found to inhibit [3H]cocaine binding and [3H]DA uptake with significantly different IC50 values, in contrast to 14 other 3 beta-substituted analogues. Molecular modeling and CoMFA analysis were used to obtain a rigorous structure-function relationship for the studied compounds. The results showed that the potencies of these 3 beta-substituted ecgonine methyl esters were dominated by steric effects and were acutely sensitive to the distance between the aryl ring and the tropane skeleton and to the orientation of the aryl ring system relative to the tropane skeleton. The current study provides a clearer picture of the shape and size of the putative hydrophobic binding pocket for the 3 beta substituent at the cocaine receptor as well as emphasizing the importance of a drug's free energy of solvation in obtaining structure-activity relationships.

Knowledge Graph

Similar Paper

(−)-3β-Substituted Ecgonine Methyl Esters as Inhibitors for Cocaine Binding and Dopamine Uptake
Journal of Medicinal Chemistry 1998.0
Synthesis of 3-carbamoylecgonine methyl ester analogs as inhibitors of cocaine binding and dopamine uptake
Journal of Medicinal Chemistry 1991.0
Synthesis of 3-arylecgonine analogs as inhibitors of cocaine binding and dopamine uptake
Journal of Medicinal Chemistry 1990.0
Synthesis, Dopamine Transporter Affinity, Dopamine Uptake Inhibition, and Locomotor Stimulant Activity of 2-Substituted 3β-Phenyltropane Derivatives
Journal of Medicinal Chemistry 1997.0
Synthesis, Cocaine Receptor Affinity, and Dopamine Uptake Inhibition of Several New 2.beta.-Substituted 3.beta.-Phenyltropanes
Journal of Medicinal Chemistry 1994.0
2.beta.-Substituted analogs of cocaine. Synthesis and inhibition of binding to the cocaine receptor
Journal of Medicinal Chemistry 1992.0
N-Modified analogs of cocaine: synthesis and inhibition of binding to the cocaine receptor
Journal of Medicinal Chemistry 1992.0
2β-Substituted Analogues of 4‘-Iodococaine:  Synthesis and Dopamine Transporter Binding Potencies
Journal of Medicinal Chemistry 1998.0
Substituted 3-phenyltropane analogs of cocaine: synthesis, inhibition of binding at cocaine recognition sites, and positron emission tomography imaging
Journal of Medicinal Chemistry 1993.0
Synthesis and Ligand Binding Studies of 4‘-Iodobenzoyl Esters of Tropanes and Piperidines at the Dopamine Transporter
Journal of Medicinal Chemistry 1997.0